20/20 BioLabs’ Multi-Cancer Early Detection Test Now Available to Evexia Diagnostics' 40,000+ U.S. Practitioners
Evexia Diagnostics now offers 20/20 BioLabs’ OneTest™ MCED test, giving clinicians affordable, biomarker insights for early cancer detection and care. WASHINGTON, CT, UNITED STATES, April 7, 2026 /EINPresswire.com/ -- Evexia Diagnostics, a leading …